| About us | Services | Products | News | Careers | Contact us |
|
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
|
MedKoo's Collection:
New anticancer agents under worldwide clinical trials
(last update: Feb 13, 2013)
Browse by Letters: A || B || C || D || E || F || G || H || I || J || K || L || M || N || O || P || Q || R || S || T || U || V || W || X || Z
201830 || 2-methoxyestradiol (angiogenesis inhibitor) 200880 || 4-demethylpenclomedine(DMPEN) (alkylation agent) 205800 || 4SC-202 (HDAC inhibitor) 205802 || 4SC-203 (multi-target kinase inhibitor) 205804 || 4SC-205 (human kinesin spindle protein Eg5 inhibitor) 202170 || Abexinostat(PCI-24781; CRA-024781) (HDAC inhibitor) 205806 || ABC294640 (sphingosine kinase-2 inhibitor) 100011 || Abiraterone (androgen biosynthesis inhibitor) 200030 || Abiraterone acetate (androgen biosynthesis inhibitor) 202852 || ABR-215050 (Tasquinimod) (angiogenic inhibitor) 205807 || ABT-199 (BCL inhibitor) 201970 || ABT-263 (Novitoclax) (Bcl-2 Inhibitor) 204140 || ABT-348 (receptor tyrosine kinase inhibitor) 206044 || ABT-414 (EGFR inhibitor) 205761 || ABT-510 (angiogenesis inhibitor) 200040 || ABT-518 (MMP inhibitor) 205896 || ABT-700 (c-MET inhibitor) 200044 || ABT-737 (BCL-2 inhibitor) 200050 || ABT-751 (Microtubule Inhibitor) 205762 || ABT-767 (PARP inhibitor) 205897 || AC430 (JAK2 inhibitor) 200078 || AC480 (BMS-599626) (HER inhibitor) 200079 || Acadesine (AMP-activated protein kinase activator) 204170 || Acolbifene (selective estrogen receptor modulator) 205808 || ACY-1215 (HDAC6 inhibitor) 201823 || Acyline (MER-104) (GnRH antagonist) 204180 || AD-1001 (immunomodulatory therapy) 200080 || Aderbasib (INCB007839) (sheddase inhibitor) 200090 || ADPM06 (PDT photosensitizer) 202042 || ADW742 (NVP-ADW742) (IGF-IR inhibitor) 200100 || AEE788 (EGFR, ErbB2, KDR, and Flt-1 inhibitor) 201475 || AEG-40826 (HGS-1029) (IAP Inhibitor) 200110 || AEG-41174 ( tyrosine kinase inhibitor) 204210 || AEW-541 (NVP-AEW541) (IGF-IR inhibitor) 204220 || AEZS-108 (AN-152) (LHRH-receptor specified doxorubicin conjugate) 200115 || AEZS-112 (ZEN012) (tubulin inhibitor) 205797 || Macimorelin (AEZS-130 (EP-1572) (growth hormone agonist) 205799 || AF802 (CH5424802) (ALK inhibitor) 200500 || Afatinib (BIBW-2992 ) (EGFR inhibitor) 200120 || Afimoxifene (selective estrogen receptor modulator) 200123 || AFP-464 (aryl hydrocarbon receptor agonist) 205810 || AFX-2 (North American ginseng extract) 204240 || AFX-9901 (anti-angiogenic agent) 204250 || AG-013 (Trefoil Factor) 200125 || AG-24322 (CDK inhibitor) 200121 || AG-490 (EGFR and JAK inhibitor) 204260 || AI-850 (cremaphor-free formulation of paclitaxel) 205942 || AKN-028 (FLT3/KIT kinase inhibitor) 200127 || AKR-501 (thrombopoietin receptor agonist) 200130 || Alanosine (antimetabolic agent; adenylosuccinate synthetase inhibitor) 200131 || ALB-109564 ( tubulin inhibitor; antimitotic agent) 200133 || Alendronate sodium (geranyltranstransferase inhibitor) 201931 || Alisertib (MLN-8237) (Aurora A kinase inhibitor) 205943 || Almurtide (CGP-11637) (immunostimulating agent) 200170 || Alvespimycin (Hsp90 inhibitor) 200180 || Alvocidib (Flavopiridol) (CDK inhibitor) 200182 || Ametantrone (DNA intercalator) 200185 || AMG-208 (c-Met inhibitor) 204310 || AMG-319 (PI3 Kinase inhibitor ) 204320 || AMG-337 (c-Met inhibitor) 205898 || AMG-458 (c-Met inhibitor) 204370 || AMG-900 (inhibitor of Aurora kinases A, B, and C.) 205944 || Aminocamptothecin (topoisomerase I inhibitor) 200200 || Amonafide dihydrohloride (topoisomerase II inhibitor) 200210 || Amonafide malate (AS-1413) (topoisomerase II inhibitor) 200220 || Amrubicin (anthracycline; DNA intercalactor; topoisomerase II inhibitor) 205769 || Amsalog (topoisomerase II inhibitor) 200720 || Amsilarotene (TAC-101) (oral synthetic retinoid) 201950 || Amuvatinib (MP-470) (Multitargeted receptor tyrosine kinase inhibitor) 204371 || AN-207 (LHRH doxorubicin conjugate) 200252 || AN-2728 (PDE4 inhibitor) 200257 || ANA-773 (TLR7 agonist) 200230 || Anamorelin (RC1291) (ghrelin receptor agonist)
205811 ||
Aneustat (OMN54) (mixture
of extracts from three commonly used Chinese medicine components; 200240 || Annamycin (DNA intercalactor; topoisomerase II inhibitor) 200250 || ANX-510 (thymidylate synthase inhibitor) 204380 || ANX-514 (docetaxel new formulation) 205899 || AP1903 (Dimerizer drug) 200255 || AP5346 (DACH polymer platinate ) 205765 || AP-26113 (dual ALK and EGFR inhibitor) 200135 || Apatinib (VEGFR inhibitor) 200140 || Apaziquone (bioreductive prodrug, hypoxia toxic agent) 205812 || APC-100 (androgen antagonist) 205813 || APC-200 (ROS inhibitor) 205814 || APC-300 (signal transduction inhibitor) 200270 || Daporinad (APO-866) (FK866) (NAMPT inhibitor) 205945 || APR-246 (p53 activator) 205894 || Apremilast (PDE4 inhibitor) 200273 || Apricoxib (COX-2 inhibitor) 200272 || AR-12 (OSU-03012) (PDK-1 inhibitor) 200275 || AR-42 (HDAC inhibitor) 205815 || Armodafinil (CNS stimulantor) 204420 || ARN-509 (androgen receptor antagonist) 206041 || ARN-810 (selective estrogen receptor degrader, SERD) 200280 || Aroplatin (DNA crosslinking agent) 205946 || ARQ-087 (pan FGFR inhibitor) 200281 || ARQ-092 (AKT inhibitor) 205947 || ARQ-171 (E2F1 pathway activator) 200284 || ARQ-501 ( R1668, beta-lapachone) (DNA damage checkpoint pathway activator) 204430 || ARQ-621 (Eg5 inhibitor) 204440 || ARQ-736 (BRAF Inhibitor) 205816 || ARQ-761 (beta-lapachone prodrug; DNA damage checkpoint pathway activator) 200290 || ARRY-300 (MEK inhibitor) 200291 || ARRY-380 (HER2 inhibitor) 205900 || ARRY-382 (cFMS inhibitor) 200292 || ARRY-520 (KSP inhibitor) 200294 || ARRY-614 (p38 and Tie2 kinase inhibitor) 200310 || Arzoxifene (selective estrogen receptor modulators (SERMs)) 205817 || AS101 (interleukin-10 inhibitor) 200296 || AS-605240 (PI3K Inhibitor) 200297 || AS703026 (MSC1936369B) (MEK 1/2 inhibitor) 205859 || AS703988 (MSC201510B) (MEK 1/2 inhibitor) 204450 || ASP-3026 (ALK inhibitor) 205818 || ASP-9521 (17βHSD5 inhibitor) 200314 || AT-101(Gossypol acetic acid) (Bcl-2 inhibitor) 205884 || AT13148 (AGC kinase inhibitor; PKB inhibitor) 200317 || AT-13387 (Hsp90 inhibitor) 204460 || AT-406 (IAP inhibitor) 200320 || AT-7519 (CDK inhibitor) 200322 || AT-9283 (multiple kinase inhibitor) 205786 || Ataluren (PTC124) (CFTR-G542X nonsense allele inhibitor) 200330 || Atamestane (aromatase inhibitor) 200340 || Atiprimod (STAT3 inhibitor) 200350 || ATN-161 (integrin alpha5beta1 inhibitor) 200360 || ATN-224 (SOD1 inhibitor) 200370 || Atrasentan (ABT-627) (endothelin A receptor antagonist) 200371 || AUY-922 (NVP-AUY922, VER-52296) (Hsp90 inhibitor) 204480 || AVL-292 (BTK inhibitor) 200390 || AVN-944 (VX-944) (IMPDH inhibitor) 200400 || Axitinib (VEGFR inhibitor) 205948 || AZD-0424 (Src/Abl kinase inhibitor) 200421 || AZD1152-HQPA (Aurora B inhibitor) 205763 || AZD-1208 (pan-PIM kinase inhibitor) 204510 || AZD-1480 (JAK2 inhibitor) 204520 || AZD-2014 (mTOR inhibitor) 204530 || AZD-2461 (PARP inhibitor) 206039 || AZD-3463 (ALK/IGF1R inhibitor) 206040 || AZD-3965 (MCT1 inhibitor) 204550 || AZD-4547 (pan-FGFR inhibitor) 200422 || AZD-4769 (EGFR tyrosine kinase inhibitor) 200424 || AZD-4877 (KSP inhibitor) 205669 || AZD-5363 (PKB/Akt inhibitor) 200426 || AZD-5438 (CDK Inhibitor) 200427 || AZD-6126 (tubulin Inhibitor) 205820 || AZD-7451 ( TRK inhibitor) 200311 || AZD-7762 (checkpoint kinase inhibitor) 200312 || AZD-8055 (mTOR inhibitor) 200298 || AZD-8931 (HER1and HER2 inhibitor) 200315 || AZM-475271 (Src tyrosine kinase inhibitor) 200316 || Bafetinib (INNO-406) (Bcr/Abl inhibitor) 205821 || BAL101553 (microtubulin inhibitor) 205822 || BAL27862 (microtubulin inhibitor) 200430 || Banoxantrone (hypoxia toxic agent) 200420 || Barasertib (AZD-1152) (Aurora B inhibitor) 202530 || Bardoxolone methyl (RTA402) (antioxidant inflammation modulator) 205893 || Baricitinib (INCB28050, LY3009104) (JAK1 and JAK2 inhibitor) 200440 || Batabulin sodium (tubulin inhibitor) 200442 || Batimastat (MMP Inhibitor) 204560 || BAY 10-00394 ( (CDK inhibitor) 205923 || BAY 10-82439 (PI3Kα/β inhibitor) 205949 || BAY 56-3722 (water soluble camptothecin derivative) 204570 || BAY 80-6946 (PI3K inhibitor) 205901 || BAY 87-2243 (HIF-1ἀ pathway inhibitor) 204590 || BAY 94-9392 (F18 tumor PET imaging agent) 205902 || BBI503 (cancer stemness kinase inhibitor) 204620 || BBI-608 (Cancer cell stemness inhibitor) 200450 || Becatecarin (DNA intercalator) 200455 || Beclometasone dipropionate (potent glucocorticoid steroid) 200460 || Belinostat (HDAC inhibitor) 205929 || Beloranib (CDK-732, ZGN-433) (MetAP-2 inhibitor) 200461 || Belotecan (camptothecin derivative; topoisomerase I inhibitor) 200470 || Bendamustine HCl (DNA alkylator) 200480 || Beraprost (prostacyclin derivative) 200490 || Berubicin (topoisomerase II inhibitor; anthracycline derivative) 200160 || Betulinic acid ( ALS357) (melanoma-specific cytotoxic agent) 204920 || Bevonium methylsulfate (also see CG-201) ( hCG inhibitor) 200491 || BEZ235 ( NVP-BEZ235) (PI3K inhibitor) 204790 || Bezielle (BZL-101) (extract of plant Scutellaria barbata; apoptosis inducer) 205888 || BGC-638 (thymidylate synthase inhibitor) 209490 || BGC-945 (ONX-0801) (thymidylate synthase inhibitor) 204640 || BGJ-398 (pan FGFR kinase inhibitor) 200492 || BGT226 (NPV-BGT226) (PI3K inhibitor) 200493 || BI-2536 (Polo-like kinase 1 inhibitor) 204670 || BI-811283 (Aurora kinase inhibitor) 200495 || BI-831266 (temporally not available) 205823 || BI-836825 (temporally not available) 205824 || BI-847325 (temporally not available) 205825 || BI-853520 (PTK2 inhibitor, focal adhesion kinase inhibitor) 200505 || BIIB-021 (CNF2024) (HSP90 inhibitor) 204676 || BIIB028 (Hsp90 inhibitor) 205826 || BIND-014 (PSMA-targeted docetaxel nanoparticles) 200515 || BIX-02188 (MEK5 inhibitor) 205951 || Bizelesin (DNA-interactive agent) 204690 || BKM-120 (PI3K inhibitor) 205878 || BKT140 (CXCR4 antagonist ) 204710 || BMN-673 (PARP inhibitor) 205952 || BMS-214662 (Farnesyltransferase inhibitor) 200520 || BMS-275183 (paciltaxel analogue, tubulin inhibitor) 200524 || BMS-536924 (IGF-IR kinase inhibitor) 200531 || BMS-641988 (androgen receptor (AR) antagonist) 200533 || BMS-690514 (VEGFR inhibitor; HER inhibitor) 200534 || BMS-754807 (IGF-1R inhibitor) 200527 || BMS-777607 (Met tyrosine kinase inhibitor) 205768 || BMS-863233 (XL-413) (CDC7 kinase inhibitor) 205767 || BMS-911543 (JAK2 inhibitor) 205827 || BMS-906024 (NOTCH inhibitor) 204740 || BMS-936558 (an anti-programmed death-1 (MDX-1106)) 204750 || BMS-936559 (an anti-programmed death-1) 204760 || BNC-105 (Vascular disrupting agent, tubulin polymerization inhibitor) 205749 || BNC105P (Vascular disrupting agent, tubulin polymerization inhibitor) 200560 || Bosutinib (Abl and Src inhibitor) 205953 || Brequidar (dihydroorotate dehydrogenase inhibitor) 200569 || Brivanib (VEGFR2 inhibitor) 200570 || Brivanib alaninate (VEGFR2 inhibitor) 204780 || BYL719 (PI3K inhbitor) 200585 || Cabazitaxel (XRP-6258) (tubulin inhibitor) 200595 || Cabozantinib ( XL-184) (VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor) 200586 || CAL-101 (PI3K inhibitor) 200600 || Canertinib 201453 || Capesaris (GTX-758) (estrogen receptor (ER) alpha agonist) 204830 || Carboxyamidotriazole orotate (CTO) 200630 || Carfilzomib (proteasome inhibitor) 204840 || CB-1400 (Not Available) 205954 || CBT-1 (MDR modulator) 205829 || CC-115 (DNA-PK/TOR kinase inhibitor) 205830 || CC-122 (Pleiotropic Pathway Modulator) 205831 || CC-1088 (selective cytokine inhibitory drug; phosphodiesterase-4 inhibitor) 205955 || CC-11006 (immunomodulatory agent) 204870 || CC-223(mTOR inhibitor) 205877 || CCX2206 (CXCR7-specific inhibitor) 200690 || Cediranib (AZD2171) (VEGF inhibitor) 200694 || Celastrol (HSP90 inhibitor) 204910 || CEP-9722 (PARP inhibitor) 200712 || CEP-11981 (VEGFR inhibitor) 200713 || CEP-18770 (proteasome inhibitor) 205903 || CEP-32496 (BRAF kinase inhibitor) 205876 || Cepharanthine (TNF-α inhibitor) 200730 || Cevipabulin (antimicrotubule agent) 205956 || CFG920 (CYP17 inhibitor) 200750 || CGC-11047 (PG-11047) 205957 || CGM097 (p53/HDM2 interaction inhibitor) 200752 || CGS-21680 (adenosine A2A receptor agonist) 205747 || CH5132799 (PI3K inhibitor) 200755 || Chelerythrine chloride 204930 || Chidamide (CS055; HBI-8000) 200770 || CHIR-265 (also see: RAF-265) 200774 || CHIR-99021 205770 || CHR-2845 (HDAC inhibitor) 205771 || CHR-3996 (HDAC inhibitor) 200776 || CHS-828 (NAD inhibitor) 205921 || CI-994 (HDAC inhibitor) 200771 || CI-1040 (also see: PD184352) 200780 || Cilengitide (αVβ3/αVβ5 integrin inhibitor ) 205832 || Cipatinib (oral tyrosine kinase inhibitor) 205612 || CKI27 (RG7304) (MEK inhibitor) 205833 || CKD-516 (microtubulin inhibitor) 204970 || CO-101 (Gemcitabine elaidate; CP-4126) (antimetabolite agent) 205796 || CO-1686 (AVL-301) (EGFR inhibitor) 200793 || Cordycepin (also see: OVI-123) 200810 || CP-547632 (VEGFR-2 inhibitor) 200820 || CP-724714 (HER2 inhibitor) 200823 || CPI-613 (metabolic inhibitor) 204990 || CPX-1 (formulation of Irinotecan + Floxuridine) 205010 || CPX-351 (formulation of cytarabine + daunorubicin) 205020 || Crenolanib (CP-868596) (PDGFR inhibitor) 202222 || Crizotinib (PF-2341066) (tyrosine kinase inhibitor) 200831 || Crolibulin (EPC2407) (tubulin inhibitor) 200841 || CUDC-101 (HDAC, EGFR and HER2 inhibitor) 205924 || CUDC-907 (a dual PI3K and HDAC inhibitor) 200842 || CVT-6883 (A2B adenosine antagonist) 205834 || CWP232204 (Wnt signaling inhibitor) 205904 || CWP232291 (Sam68 modulator) 200848 || CX-5461 (RNA polymerase I Inhibitor) 200844 || CYC-116 (Aurora kinase/VEGFR2 inhibitor) 200786 || CYT-387 (JAK inhibitor) 205959 || Cytochlor (radio-sensitizing agent) 205748 || Lexibulin (CYT997) (Vascular disrupting agent) 205479 || Dabrafenib (GSK-2118436) (B-RAF inhibitor) 200845 || Dacinostat (NVP-LAQ824) 205576 || Dacomitinib (PF-00299804) (EGFR inhibitor) 205960 || Daniquidone (Batracylin) (DNA topoisomerase inhibitor) 200846 || Danusertib (PHA-739358) (Aurora kinase inhibitor) 200850 || Darinaparsin (ZIO-101) 200851 || DCC-2036 (BCR-ABL inhibitor) 205737 || Debio-0932 (CUDC-305) (Hsp90 inhibitor) 200890 || Denibulin (MN-029) (microtubule inhibitor; vascular-disrupting agent) 201000 || Dexmethylphenidate (NDRI inhibitor) 206008 || Diazepinomicin (TLN-4601) (RAS/RAF/MAPK inhibitor) 205999 || Dilmapimod (SB-681323) (GW-681323)(p38 MAPK inhibitor) 202572 || Dinaciclib (SCH-727965, PS-095760) (CDK inhibitor) 200880 || DMPEN(4-demethylpenclomedine) (alkylation agent) 201060 || Docosahexaenoic acid 201065 || Dofequidar (P-glycoprotein inhibitor; MDR inhibitor; sphingomyelin synthase inhibitor) 201040 || Doramapimod (p38 MAPK inhibitor) 200760 || Dovitinib (TKI-258, CHIR258) (fibroblast growth factor receptor 3 (FGFR3) inhibitor) 205835 || DS-2248 (Hsp90 inhibitor) 205961 || DS-3078a (TORC1/2 kinase inhibitor) 205836 || DS-7423 (PI3K/mTOR kinase inhibitor) 205837 || E-3810 (VEGFR/FGFR dual kinase inhibitor) 201071 || E6201 ( MEK-1/MEKK-1 inhibitor) 205150 || E7016 (PARP inhibitor) 201072 || Golvatinib (E7050) ( c-Met/VEGFR kinase inhibitor) 205882 || E7449: (PARP inhibitor) 201090 || E7820 (angiogenesis inhibitor) 201150 || Edatrexate 201160 || Edotecarin (PHA-782615; J-107088; ED-749) (topoisomerase inhibitor) 201180 || Efaproxiral (radiosensitizer) 205260 || Eflornithine (CPP-1X) 201190 || Elacridar (P-glycoprotein inhibitor) 201195 || Elacytarabine (antimetabolite agent) 201200 || Elagolix ( NBI-56418) 201210 || Elesclomol (HSP-90 Inhibitor) 201220 || Elinafide (DNA intercalator) 202300 || Elisidepsin (PM-02734) 205828 || Elomotecan (BN-80927) (topoisomerase inhibitor) 201230 || Elsamitrucin (DNA intercalator) 201240 || Eltrombopag (thrombopoietin receptor agonist) 205330 || EMD-1204831 (c-MET inhibitor) 201245 || EMD-1214063 (c-Met inhibitor) 206035 || EMD534085 (Kinesin inhibitor) 201250 || Eniluracil (dihydropyrimidine dehydrogenase inhibitor) 201260 || ENMD-1198 (antimitotic agent) 201264 || ENMD-2076 (Aurora kinase inhibitor) 201266 || Entinostat (MS-275, SNDX-275) (HDAC inhibitor) 201821 || Enzalutamide (MDV3100) (selective androgen receptor modulator) 201270 || Enzastaurin (LY317615) (protein kinase C beta inhibitor) 201275 || Epofolate (BMS-753493) (folate receptor-targeting antimitotic agent) 201280 || Epothilone D ) (tubulin inhibitor) 205892 || EPZ-5676 (DOT1L inhibitor and HMT inhibitor) 201290 || Eribulin mesylate (E7389) (tubulin inhibitor) 205510 || Erismodegib (LDE225, NVP-LDE225) (Smo antagonist) 201310 || Etalocib (LY293111) (LTB4 receptor antagonist) 206031 || Etanidazole (SR-2508) (bioreductive drug) 205230 || Etarfolatide (EC-20) (tumor imaging agent) 201320 || Ethonafide 100335 || Everolimus 201340 || Exatecan (topoisomerase inhibitor) 201360 || Ezatiostat (glutathione S-transferase P1-1 (GSTP1-1) inhibitor) 205962 || Fadrozole (aromatase inhibitor) 205950 || Falnidamol ((EGFR inhibitor) 205935 || Famitinib (multi-targeted RTK inhibitor) 205963 || Fazarabine (Kymarabine) (DNA synthesis inhibitor) 205430 || Fenretinide (RAR agonist) 205380 || Firtecan pegol (EZN-2208) (Pegylated SN-38, drug conjugate) 201372 || Foretinib (XL880, SK1363089, GSK089, EXEL-2880) (MET/VEGFR2 inhibitor) 201390 || Forodesine 205461 || Fosaprepitant (antiemetic agent) 200800 || Fosbretabulin (combretastatinA-4phosphate, CA4P) (vascular disrupting agent) 205965 || Fosquidone (topoisomerase inhibitor) 201393 || Fostamatinib (R788) (Syk kinase inhibitor) 205465 || FT-1050 (Stem Cell Modulator) 205646 || Galeterone (TOK-001) 202703 || Ganetespib (STA-9090) (Hsp90 inhibitor) 205746 || GDC-0032 (PI3K inhibitor) 205467 || GDC-0068 (AKT inhibitor) 205764 || GDC-0152 (IAP inhibitor, Smac mimetic) 205840 || GDC-0425 (RG7602) (ChK-1 inhibitor) 205841 || GDC-0575 (ChK1 selective inhibitor) 205772 || GDC-0623 (MEK inhibitor) 205468 || GDC-0917 (IAP inhibitor) 201395 || GDC-0941 (PI3K inhibitor) 203185 || GDC-0973 (XL518) (MEK inhibitor) 205470 || GDC-0980 (RG7422) ( PI3 kinase/mTOR inhibitor) 205471 || GENZ-644282 (A non-camptothecin inhibitor of topoisomerase I) 205922 || Geldanamycin (HSP 90 inhibitor) 205798 || GFB-204 (VEGFR and PDGFR inhibitor) 205472 || GGTI-2418 (geranylgeranyltransferase I inhibitor) 201410 || Gimatecan (topoisomerase inhibtor) 205774 || Givinostat (ITF2357) (HDAC inhibitor) 205842 || GLPG0187 (integrin receptor antagonist) 205843 || GO-203-2C (MUC1-targeted peptide) 201430 || Gossypol (Bcl-2 inhibitor) 201440 || GPX100 (anthracycline, DNA intercalator) 201450 || GPX150 (anthracycline, DNA intercalator) 205475 || GRN-1005 (ANG-1005) (paclitaxel conjugate, microtube inhibitor) 205966 || GS-9820 (p110beta/delta PI3K Inhibitor) 205739 || GSK-1059615 (mTOR inhibitor) 205477 || GSK-1070916A (Aurora B/C kinase inhibitor) 205478 || GSK-2110183 (AKT inhibitor) 205480 || GSK-2126458 (PI3K inhibitor, mTOR inhibitor) 205481 || GSK-2141795 (Akt inhibitor) 205484 || GSK-2586881 (APN01) 205844 || GSK-2636771 (PI3K inhibitor) 205667 || GSK-461364 (PLK inhibitor) 205697 || GSK-525762 (BET inhibitor) 205670 || GSK-690693 (pan-Akt kinase inhibitor) 205036 || GSK-923295 (Kinesin inhibitor) 205766 || Gusperimus (immunosuppressant agent) 205845 || Henatinib (multitargeted tyrosine kinase inhibitor) 201466 || Hesperadin
401510 || HM30181
201480 || HMN-176 (PLK-1 inhibitor) 201490 || HMN-214 (PLK-1 inhibitor) 205487 || HSP-990 (HSP inhibitor) 205735 || Hycanthone (Topoisomerase inhibitor, DNA intercalator) 205879 || Laniquidar (R101933) (Oral P-glycoprotein Inhibitor) 202171 || Ibrutinib (PCI-32765) (BTK inhibitor) 201684 || Ibutamoren 205847 || Icotinib (EGFR inhibitor) 205880 || Idoxifene (estrogen antagonist) 205489 || Imetelstat (GRN-163L) 201500 || Imexon (caspase inhibitor) 205886 || IMMU-132 (antibody-SN38 conjugate) 205492 || IMO-2055 (EMD1201081) 205494 || INC280 (INCB-028060) (c-MET inhibitor, RTK inhibitor) 205493 || INCB024360 (IDO1 inhibitor) 201530 || Indibulin (ZIO-301) (tubulin inhibitor) 206023 || Indirubin (CDK inhibitor) 201540 || Indisulam (carbonic anhydrase inhbitor) 205971 || Indomethacin (COX inhibitor) 201545 || Ingenol Mebutate (PEP005) 200582 || Iniparib (BSI-201) (PARP inhibitor) 201550 || INNO-206 (DNA intercalating agent) 205250 || Inolitazone (CS-7017, Efatutazone ) 200496 || Nintedanib ( BIBF-1120) (VEGFR inhibitor) 201570 || Iobenguane 205496 || Ioflubenzamide I-131 (MIP-1145) 205744 || IPI-145 (INK-1197) (PI3K inhibitor) 205773 || IPI-269609 (Hedgehog pathway inhibitor) 200550 || Irosustat (STX64, BN83495) 205906 || IRX4204 (RXR agonist) 205907 || IRX4310 (pan-RAR antagonist) 201590 || Isatoribine (toll-like receptor 7 (TLR-7) agonist) 205848 || Iso-Fludelone (microtubulin inhibitor) 205541 || Ixazomib (MLN-9708) (the first oral proteasome inhibitor) 201615 || JNJ-38877605 (tyrosine kinase inhibitor) 205972 || JNJ-40346527 (FMS inhibitor) 205973 || JNJ-42756493 (FGFR inhibitor) 205849 || JNS002 (Pegylated liposomal doxorubicin) 201630 || Karenitecin (Cositecan, BNP-1350). 205891 || Kevetrin (Protein p53 activator) 206021 || KP1019 (ruthenium metastasis inhibitor) 205883 || KPT-330 (Selective Inhibitor of Nuclear Export, SINE) 205868 || KRN7000 (RGI-2001) (immunomodulator) 205775 || KRP-203 (Sphingosine-1-phosphate receptor agonist) 203060 || KRX-0601(also see UCN-01) 205776 || KU-0063794 (mTOR inhibitor)
206034 ||
KU-2285 205908 || KW-2450 (IGF-1R/IR inhibitor) 205506 || KW-2478 (Hsp90 inhibitor) 205927 || KX-01 ( Src kinase inhibitor) 201686 || KX2-391 (rc kinase inhibitor) 205974 || L-377202 (doxorubicin conjugate) 201705 || Laromustine(VNP40101M) 205909 || LCI699 (aldosterone synthase inhibitor) 205511 || LDK-378 (ALK inhibitor) 205512 || LE-DT (Liposome Encapsulated Docetaxel) 205993 || Ledoxantrone (topoisomerase II inhibitor)
201724
|| Lemuteporfin
(QLT-0074)
(PDT photosensitizer) 201080 || lenvatinib (E7080) 205514 || LEP-ETU (liposomal paclitaxel, PNU-93914) 205975 || Lerisetron (3,5-HT3) receptor antagonist) 205895 || Letaxaban (TAK-442) (Factor Xa inhibitor) 100542 || Levoleucovorin Calcium 205850 || LGH447 (PIM inhibitor) 205851 || LGK-974 (Porcupine inhibitor) 205852 || LGX818 (Raf kinase inhibitor) 205976 || Liarozole (retinoic acid metabolism blocking agent) 200060 || Linifanib ( ABT869) (RTK inhibitor) 202096 || Linsitnib (OSI-906) (IGF-1R inhibitor) 205521 || Litronesib (aslo see: LY2523355) 205977 || Lometrexol (GARFT inhibitor; anti-metabolizing agent) 201760 || Lonafarnib (farnesyl transferase inhibitor) 205910 || Lonaprisan (progesterone receptor antagonist) 205517 || LOR-253 (MTF-1 inhibitor) 205853 || LOR-500 (MELK inhibitor) 206028 || Losoxantrone (DNA intercalator, bioreductive drug) 201780 || Lucanthone (Topoisomerase inhibitor, DNA intercalator) 205594 || Lurbinectedin (PM-01183) (DNA minor groove-binding agent) 205783 || Lurtotecan (OSI-221; NX221) (topoisomerase I inhibitor) 205518 || LY2090314 (GSK-3 inhibitor) 205520 || LY2157299 (TGF-βR inhibitor) 205854 || LY2228820 (p38MAPK inhibitor) 201792 || LY2334737 (antimetabolite agent)
205925 || 201794 || Rabusertib (LY2603618) (CHK2 inhibitor) 205524 || LY2624587 (not available) 205525 || LY2780301 (AKT inhibitor) 206032 || LY2784544 (JAK inhibitor) 205526 || LY2801653 (c-MET inhibitor) 205911 || LY2835219 (CDK inhibitor) 205527 || LY2874455 (FGFR inhibitor) 205528 || LY2875358 (anti-c-MET monoclonal antibody) 201795 || LY294002 (PI3K inhibitor) 205855 || LY3007113 (p38 MAPK inhibitor) 205912 || Macitentan (endothelin receptor antagonist) 205978 || Mafosfamide (DNA cross-linking agent) 201802 || Marimastat (BB-2516) 202031 || Marizomib (NPI-0052) (proteasome inhibitor) 201804 || Masitinib (AB1010) (tyrosine kinase inhibitor) 205741 || Maytansine (microtubule inhibitor) 201810 || Imisopansem manganese (MB07133) 205782 || ME-143 (NV-143) (NADH oxidase inhibitor) 205856 || ME-344 (mTOR1/2 kinase inhibitor) 205531 || MEK-162 (ARRY-162) (MEK1/2 inhibitor) 205650 || Methoxyamine (TRC102) (DNA base excision repair (BER) inhibitor) 205533 || Methyl aminolevulinate (PDT photosensitizer) 205671 || MG-516 (multi-targeted kinase inhibitor) 201841 || MGCD-265 (multitargeted tyrosine kinase inhibitor) 201850 || Midostaurin (PKC412) 201860 || Mifamurtide (L-MTP-PE. MTP-PE) (immunomodulatory agent) 202233 || Milciclib (PHA-848125) (CDK inhibitor and TRKA inhibitor) 205979 || Mitoguazone (SAMD inhibitor) 205980 || Mivobulin isethionate (microtubule inhibitor) 201891 || MK-0429 (ανβ3 Integrin Inhibitor) 201910 || MK-0731 (KSP inhibitor) 201911 || MK-0752 (notch inhibitor) 205537 || MK-1496 (Polo-like kinase 1 inhibitor) 201912 || MK-1775 (WEE inhibitor) 201913 || MK-2206 (Akt inhibitor) 201914 || MK-2461 (Multitargeted Kinase Inhibitor) 201915 || MK-4101 (not available) 201916 || MK-4827 (PARP inhibitor) 201917 || MK-5108 (VX-689) ( Aurora-A kinase inhibitor) 201918 || MK-8033 (c-MET inhibitor) 205495 || MLN0128 (INK-128) (mTOR inhibitor) 205743 || MLN1117 (INK-1117) (PI3K inhibitor) 205857 || MLN-2238 (oral proteasome inhibitor, metabolite of MLN9708) 205777 || MLN-2480 (Raf kinase inhibitor) 201924 || MLN-4924 (NAE inhibitor) 201930 || MLN-8054 (aurora kinase inhibitor) 205858 || MM-151 (EGFR inhibitor) 205720 || MM-302 (HER2-targeted liposomal doxorubicin) 205543 || MM-398 (irinotecan nanotherapy) 201933 || Mocetinostat (MGCD-0103) (HDAC inhibitor) 201934 || Motesanib (AMG-706) (tyrosine kinase inhibitor) 201940 || Motexafin gadolinium (PDT photosensitizer, radiosensitizer) 201942 || Motexafin lutetium (PDT photosensitizer, radiosensitizer) 201944 || MP-412 (AV-412) (EGFR/HER2 tyrosine kinase inhibitor) 205544 || MPC-3100 (Hsp90 inhibitor) 205885 || MRK 003 (γ-secretase inhibitor; Notch inhibitor, Hedgehog inhibitor) 201961 || MSX-122 (CXCR4 inhibitor) 205549 || Nabiximols 206020 || NAMI-A (ruthenium metastasis inhibitor) 206017 || Nebentan (YM598) endothelin A receptor antagonist) 201470 || Neratinib (HKI272) (HER2 and EGFR inhibitor) 205981 || Netupitant (NK1 receptor antagonist) 205940 || Niclosamide (Stat inhibitor) 205934 || Nifurtimox 201990 || Nilotinib (Bcr-Abl inhibitor) 205860 || Nitroarginine (NG-nitro-L-arginine) (nitric oxide synthase inhibitor) 205551 || NK-012 (SN-38-PEG conjugate, camptotecin conjugate) 205740 || NKP-1339 (ruthenium-based transferrin targeting agent) 205742 || NKP-2235 (gallium-based small molecule) 205778 || NMS-1116354 (CDC7 kinase inhibitor) 205779 || NMS-1286937 (PLK1 inhibitor) 202010 || Nolatrexed 202020 || Noscapine (also see CB-3304) 202030 || NOV-002 (chemoprotective agent) 201970 || Novitoclax (ABT-263) (Bcl-2 Inhibitor) 205982 || NRX-19583 (RAR alpha agonist) 202041 || NRX-4204 (NRX19402) (retinoid X receptor (RXR) agonist) 205861 || NS-018 (JAK2/Src inhibitor) 205557 || NUC-1031 (a phosphoramidate ProTide) 205780 || NV-128 (mTOT inhibitor) 202050 || Obatoclax ( GX15-070) (BCL-2 Inhibitor) 202062 || Odanacatib (MK-0822) (protease inhibitor) 206043 || ODM-201 (androgen receptor inhibitor) 202064 || Oglufanide 200423 || Olaparib (AZD-2281) (PARP inhibitor) 202070 || Oleandrin (PBI-05204) 205913 || Oltipraz (chemopreventive agent) 202075 || Omacetaxine mepesuccinate (Homoharringtonine) 200380 || Ombrabulin (AVE8062) (tubulin inhibitor) 205914 || ONO-4059 (BTK inhibitor) 205983 || ONO-7746 (TPO receptor agonist ) 202087 || ONT-093 (OC144-093) (P-glycoprotein pump inhibitor) 205565 || ONX-0912 (proteasome inhibitor) 205730 || ONX-0914 (immunoproteasome inhibitor) 205566 || OPB-31121 (STAT3 inhibitor) 205567 || OPB-51602 (STAT3 inhibitor) 205890 || OKN-007 (neuroprotective nitrone) 205984 || Ormaplatin (DNA alkylating agent) 202090 || Ortataxel (taxane microtube inhibitor) 200724 || Orteronel (TAK-700) (steroid 17alpha-monooxygenase inhibitor) 202094 || OSI-027 (mTOR inhibitor) 205569 || OSI-7904L (GS7904L, OVI-237 ) (inhibitor of thymidylate synthase) 202103 || Ostarine (MK-2866, GTX-024) 205985 || OTX008 (galectin-1 inhibitor) 202110 || Ozarelix (also see: SPI-153) 205936 || P7170 (PI3K, mTOR and ALK1 inhibitor) 202118 || P276-00 (DCK inhibitor) 205571 || PA799 (PI3K class I inhibitor) 206029 || PA-824 (bioreductive drug) 205932 || PAC-1 (procaspase activator) 202571 || Pacritinib (SB1518) 205760 || Padeliporfin (WST11, Stakel) (PDT photosensitizer)
202185
|| Padoporfin
(Tookad)
(PDT photosensitizer) 202130 || Palifosfamide (ZIO-201) 202133 || Palomid 529 (PI3K inhibitor; Akt inhibitor; mTOR inhibitor) 202151 || Panobinostat (NVP-LBH589; LBH589) (HDAC inhibitor) 205572 || Pasireotide (SOM-230) ( somatostatin receptor agonist) 202161 || Pazopanib (GW786034) (tyrosine kinase inhibitor ) 205574 || PCI-27483 (factor VIIa inhibitor) 202172 || PD-0325901 (MEK inhibitor) 202173 || PD-0332991 (CDK Inhibitor) 202174 || PD-153035 (EGFR inhibitor) 205915 || Pegdinetanib (VEGFR-2 inhibitor peptide) 202190 || Pelitinib (EKB569) (pan-ErbB tyrosine kinase inhibitor) 202200 || Pelitrexol (GARFT inhibitor) (glycinamide ribonucleotide formyltransferase) 205986 || Peretinoin (RAR agonist) 202220 || Perifosine (AKT Inhibitor) 205916 || PF-00337210 (VEGFR2 tyrosine kinase inhibitor) 202223 || PF-03732010 (antibody drug, p-cadherin antagonist) 205581 || PF-03758309 (PAK4 inhibitor) 205987 || PF-03814735 (Aurora kinase inhibitor) 205988 || PF-04136309 (CCR2 antagonist) 202221 || PF-04217903 ( MET tyrosine kinase inhibitor) 205583 || PF-04554878 (FAK inhibitor) 202226 || PF-04691502 (PI3K/mTOR inhibitor) 202227 || PF-0477736 (CHK inhibitor) 202228 || PF-0562271 (PF-562271; PF-00562271) (a FAK inhibitor) 202231 || PHA-665752 (c-MET inhibitor) 206024 || PHA-793887 (CDK inhibitor)
202242
|| Photochlor
(PDT photosensitizer)
202235 || PI-103 (PI3K inhibitor, and mTOR inhibitor) 202230 || Picoplatin 205819 || Picropodophyllin (AXL1717) (IGF-1 receptor inhibitor) 202238 || PIK-75 (PI3K inhibitor) 206030 || Pimonidazole (bioreductive drug) 205784 || Piroxantrone (topoisomerase II inhibitor) 205928 || Pivanex (AN-9) (HDAC inhibitor) 202250 || Pixantrone 205989 || PKI-179 (PI3Ka/mTOR inhibitor) 202255 || PKI-587 (PF-05212384) (Dual PI3 Kinase/mTOR Inhibitor) 202260 || Plerixafor 202270 || Plevitrexed (BGC-9331) 202040 || Plinabulin (NPI-2358) 200150 || Plitidepsin (Aplidine) 205592 || PLX-3397 (multitargeted tyrosine kinase inhibitor) 202272 || PLX-4720 (B-Raf inhibitor) 205596 || PNT-2258 (an oligonucleotide therapeutic encapsulated within a SMARTICLES formulation). 205514 || PNU-93914 (liposomal paclitaxel, LEP-ETU) 205864 || POL6326 (CXCR4 inhibitor) 202320 || Ponatinib (AP-24534) (tyrosine kinase inhibitor) 202324 || PP242 (mTOR inhibitor) 205887 || PR610 (hypoxia-activated prodrug, pan-HER inhibitor) 205626 || Pracinostat (SB939) (HDAC inhibitor) 202320 || Pralatrexate (dihydrofolate reductase inhibitor) 205865 || PRI-724 (CBP/beta-catenin antagonist; Wnt signaling pathway inhibitor) 202334 || PRLX-93936 205597 || PRT-062607 205598 || PRX-302 (protein drug) 205599 || PTC-299 (VEGF inhibitor) 205601 || PTI-188 (a radiolabeled murine anti-melanin antibody) 205678 || PU-H71 (Hsp90 inhibitor) 205745 || PWT33597 (PI3K inhibitor) 202350 || PX-478 (HIF-1alpha inhibitor) 202360 || PX-866 (PI3K inhibitor) 202370 || Pyroxamide 205866 || PZP115891 205603 || QBI-139 (protein drug) 202380 || Quarfloxin (CX-3543) (G-quadruplex-interactive agent) 202385 || Quinacrine (Mepacrine ; CBLC102) 202390 || Quinagolide (D2 receptor agonist) 201612 || Quisinostat (JNJ-26481585) (HDAC inhibitor) 200072 || Quizartinib (AC220) (FLT3 inhibitor) 202391 || R1530 (Mitosis-angiogenesis inhibitor) 202411 || R306465 (JNJ-16241199)( HDAC inhibitor) 205926 || R406 (Syk inhibitor) 202422 || R763 (AS703569) (Aurora kinase inhibitor) 205990 || Radotinib (tyrosine kinase inhibitor) 202432 || RDEA-436 (MEK inhibitor) 205991 || Rebimastat (BMS-275291) (MMP inhibitor) 202431 || Refametinib (RDEA119; BAY86-9766) (MEK inhibitor) 202436 || Regorafenib (BAY 73-4506) (oral multi-kinase inhibitor) 205867 || Resiquimod (Toll-like receptor (TLR) agonist) 205787 || Resminostat (4SC-201) (HDAC inhibitor) 202701 || Resveratrol(RM1812 , SRT-501) 202450 || Retaspimycin (IPI504) (HSP90 inhibitor) 205609 || RG-7167 (MEK inhibitor) 205917 || RG7388 (MDM2 antagonist) 200860 || Ridaforolimus (Deforolimus) 202080 || Rigosertib(ON-01910 ) (PLK1 inhibitor) 202701 || RM1812 (resveratrol, SRT-501) 202412 || RO4929097 (R4733) (gamma-secretase/Notch signalling pathway inhibitor) 202462 || RO4987655 (MEK inhibitor) 202421 || RO5045337 ( RG7112, R7112) (MDM2 (human homolog of double minutes-2; HDM2) antagonist) 205788 || RO5126766 (Raf/MEK dual kinase inhibitor) 205869 || RO518426 (V600E BRAF Blocker) 205611 || RO5212054 (PLX3603, RG-7256) (BRAF(V600E) kinase inhibitor) 205789 || RO5503781 (MDM2 antagonist) 202470 || Rolapitant (NK1 receptor antagonist) 202500 || Roquinimex (immunostimulant) 202510 || Rosabulin (STA-5312) (microtubule inhibitor)
202514
|| Rostaporfin
(PDT photosensitizer)
200124 || Rucaparib (PF-01367338, AG-14699) (PARP1 inhibitor) 201512 || Ruxolitinib (INC-424; INCB-18424) (JAK1 inhibitor) 205992 || S-3304 (MMP inhibitor) 205767 || Sabarubicin (DNA intercalator) 203210 || Sagopilone (ZK epothilone) 205889 || SAR125844 (MEK inhibitor) 205624 || SAR411298 (FAAH inhibitor. Cancer pain) 200410 || Saracatinib (AZD-0530) (Src and Abl inhibitor) 200411 || Sardomozide ( SAMDC inhibitor) 201572 || Saridegib (IPI-926) (Hedgehog pathway inhibitor) 205791 || SB-1518 (JAK2 inhibitor) 205790 || SB-743921 (KSP inhibitor) 202573 || SCH900776 (Chk1 inhibitor) 202580 || Seliciclib (CDK inhibitor) 200300 || Selumetinib (AZD-6244) (MEK 1/2 inhibitor) 205994 || Semaxanib (VEGFR2 inhibitor) 202600 || Seocalcitol (CB1089) 203190 || Sepantronium (YM-155) (Survivin inhibitor) 201614 || Serdemetan (JNJ-26854165) 205629 || SGI-110 (DNMT inhibitor) 205710 || SGI-1776 (pan-Pim protein kinase inhibitor) 205630 || SGN-75 (anti-CD70 monoclonal antibody) 205715 || SGX-523 (Met Inhibitor) 205918 || SGX201 (active corticosteroid) 205871 || SHP-141 (HDAC inhibitor) 200274 || Silatecan (AR-67; DB-67) (topoisomerase I inhibitor; camptotecin derivative) 202610 || Silibinin ( extract of the milk thistle seeds; mixture of flavonolignans) 200843 || Silmitasertib (CX-4945) (CK2 inhibitor) 200540 || SJG-136 (BN2629, SG2000) (DNA replication inhibitor) 202630 || SN-2310 (SN-38 conjugate with VE; topoisomerase I inhibitor) 202640 || SNS-032 (BMS-387032) (CDK inhibitor) 202641 || SNS-314 (Aurora kinase inhibitor) 205736 || SNX-2112 (HSP90 inhibitor) 202651 || SNX-5422 (PF-4929113) 202660 || Soblidotin (tubulin polymerization inhibitor)
205627
|| Sonoflora
1
( SF1)
(PDT photosensitizer) 205809 || Sotrastaurin (AEB071) (PCK inhibitor) 205872 || SPI-1005 (ebselen-containing oral capsule) 202690 || Squalamine 205672 || SR13668 (Akt inhibitor) 206027 || SR4554 (bioreductive drug) 202700 || SR-31747 (Peripheral sigma receptor antagonist) 202715 || STA-1474 (Prodrug of ganetespib) (HSP90 inhibitor) 202708 || Stannsoporfin (heme oxygenase inhibitor) 205633 || Sufentanil (ARX-02) 202713 || Sulforaphane (natural antioxidant) 205995 || Sulofenur (sulfonylurea) 205873 || SYP-0704A 205996 || T900607 (microtuble inhibitor) 205997 || Tacedinaline (HDAC inhibitor) 202045 || TAE684 (NVP-TAE684) (ALK Inhibitor) 202721 || TAK-285 (HER2/EGFR dual kinase inhibitor) 205919 || TAK-385 (GnRH receptor antagonist) 205635 || TAK-441 (Hedghog inhibitor) 202722 || TAK-593 (VEGFR/PDGFR dual kinase inhibitor) 205638 || TAK-733 (MEK inhibitor) 202725 || TAK-901 (Aurora B kinase inhibitor ) 205639 || TAK-960 (PLK1 inhibitor) 202730 || Talabostat 202740 || Talampanel (AMPA-receptor antagonist) 202750 || Talaporfin sodium (PDT photosensitizer) 205998 || Talmapimod (MAKP inhibitor) 202760 || Taltobulin (tubulin inhibitor) 202780 || Tamibarotene (retinoic acid receptor (RAR) alpha/beta agonist) 202790 || Tandutinib (MLN0518) (tyrosine kinase inhibitor) 202953 || Tanomastat (matrix metalloprotease inhibitor) 100803 || Tapentadol 202810 || Tarenflurbil ((NSAID drug, enantiomer of flurbiprofen) 202820 || Tariquidar (p-glycoprotein inhibitor) 202834 || TAS-103 (BMS-247615) 202840 || TAS-108 (estrogenic receptor alpha (ERa) inhibitor) 202841 || TAS-109 (DNA polymerase inhibitor) 202851 || Tasisulam (LY573636) 202852 || Tasquinimod (ABR-215050) (angiogenic inhibitor) 206001 || TCD-717 (CHKA inhibitor) 202860 || Teglarinad chloride (GMX-1777) 200680 || Telapristone (CDB-4124) (progesterone receptor modulator) 202950 || Telatinib ( Tanespimycin) (Hsp90 inhibitor) 206002 || Teloxantrone (topoisomerase II inhibitor)
202865
|| Temoporfin
(PDT photosensitizer) 202880 || Terameprocol (transcriptional inhibitor) 205875 || Teriflunomide (A77 1726; HMR1726) (Dihydrorotate dehydrogenase inhibitor; immunomodulatory drug) 206004 || Tezacitabine (ribonucleotide reductase inhibitor) 205793 || TG-0054 (CXCR4 antagonist) 205642 || TG02 (multi-kinase inhibitor of CDKs, JAK2 and FLT3) 202892 || TG100-115 (PI3K inhibitor) 202893 || TG101348 ( JAK2 inhibitor) 205938 || TGR-1202 (PI3K delta inhibitor) 202895 || TGX-221 (PI3K inhibitor) 202901 || TH-302 (hypoxia-activated prodrug) 205644 || Thiarabine 201955 || Thymectacin (NB-1011). 206005 || Tiazofurin (IMPDH inhibitor) 202921 || Tigapotide 202930 || Tipifarnib (farnesyl transferase inhibitor) 206037 || Tipiracil (antimetabolite drug) 202940 || Tirapazamine (hypoxia toic agent) 200283 || Tivantinib (ARQ-197) (c-Met inhibitor) 202955 || Tivozanib (AV-951) (VEGFR inhibitor) 205645 || TL32711 (Smac mimetic) 206007 || TLN-232 (pyruvate kinase inhibitor) 205738 || Toceranib (SU11654) (Hsp90 inhibitor) 200811 || Tofacitinib (CP-690550) (JAK inhibitor) 100880 || Toremifene 205648 || Tosedostat 201900 || Tozasertib (MK-0457; VX-680) (Aurora inhibitor) 206003 || TPCS2a (Tetraphenyl chlorin disulfonate) (PDT photosensitizer) 201458 || Trametinib (GSK-1120212, JTP-74057) (MEK 1/2 inhibitor) 205881 || Trastuzumab emtansine (trastuzumab (Herceptin) linked to the cytotoxin mertansine (DM1)) 205652 || Treosulfan 202980 || Tretazicar (DNA alkylating agent) 203000 || Triapine (ribonucleotide reductase inhibitor) 203010 || Triciribine (VQD-002) (Akt inhibitor) 206038 || Trifluridine (antimetabolite drug) 203020 || Trilostane 206009 || TriN2755 (DNA cross linking agent) 206010 || Trofosfamide (DNA cross linking agent) 206011 || TTP607 (Aurora kinase inhibitor) 203055 || Tubacin (HDAC6 inhibitor)
205939
|| 205655 || TXA127 (heptapeptide COX-2 inhibitor) 203160 || Upamostat (Mesupron, WX-671) (serine protease inhibitor) 203091 || Ursodeoxycholic acid ( Ursodiol) 203091 || Ursodiol ( Ursodeoxycholic acid) 201050 || Vadimezan (AS-404; DMXAA) (vascular disrupting agent) 205920 || VAL-083 (alkylating agent) 203100 || Vandetanib (approved in 2011) (VEGFR and EGFR inhibitor) 205660 || Varlitinib ( ARRY-543) (EGFR inhibitor) 203110 || Vatalanib (VEGFR inhibitor) 203115 || Veliparib ( ABT-888) (PARP inhibitor) 202271 || Vemurafenib (RG7204, PLX4032, RO5185426) (B-Raf inhibitor) 203120 || Verteporfin (PDT photosensitizer) 201960 || Verubulin (MPC-6827) 203150 || Vinflunine 203500 || Vismodegib (RG3616, GDC-0449) (Hedgehog antagonist) 200494 || Volasertib ( BI-6727) (Plk1 inhibitor) 202650 || Voreloxin (SNS-595, Vosaroxin) (topoisomerase II inhibitor) 205941 || VRT-043198 (Caspase inhibitor) 203152 || VP-701 (not available) 203162 || VX-702 (p38 MAPK Inhibitor) 203165 || VX-765 (Caspase inhibitor) 206012 || WX-554 (MET inhibitor) 203170 || WZ4002 (EGFR inhibitor) 206013 || X-396 (ALK inhibitor) 203180 || Xaliproden 206014 || XK469 (topoisomerase II-beta inhibitor) 205794 || XL019 (JAK2 Inhibitor) 203181 || XL147 (SAR-245408) (PI3K inhibitor) 206015 || XL418 (protein kinase B inhibitor) 203186 || XL647 (EGFR and ErbB2 inhibitor) 203187 || XL765 (SAR-245409) (PI3K/mTOR inhibitor) 206016 || XL820 (receptor tyrosine kinase inhibitor) 205930 || XL844 (CHK inhibitor) 205750 || XL888 (Hsp90 inhibitor) 205665 || XL999 (Spectrum Selective Kinase Inhibitor) 206018 || Z-360 (gastrin/ CCK-2) receptor antagonist) 203200 || Zibotentan (AZD-4054, ZD4054) 206025 || ZK-304709 (multi-target tumor growth inhibitor) 206019 || Zorubicin (topoisomerase II inhibitor) 203220 || Zosuquidar (P-glycoprotein inhibitor) 205795 || ZSTK474 (PI3K inhbitor) |
Contact MedKoo: Email: sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
About us | Services | Products | News | Careers | Contact us